HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luciano Adorini Selected Research

Ursodeoxycholic Acid (Urso)

1/2018A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis.
4/2015Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luciano Adorini Research Topics

Disease

27Inflammation (Inflammations)
01/2024 - 12/2002
16Fibrosis (Cirrhosis)
12/2023 - 12/2009
13Autoimmune Diseases (Autoimmune Disease)
05/2009 - 01/2002
8Type 1 Diabetes Mellitus (Autoimmune Diabetes)
08/2011 - 05/2002
7Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2018 - 01/2011
6Non-alcoholic Fatty Liver Disease
01/2024 - 04/2013
6Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
07/2012 - 06/2006
5Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2020 - 06/2009
5Insulin Resistance
12/2019 - 01/2013
5Atherosclerosis
10/2018 - 08/2011
5Proteinuria
01/2018 - 12/2009
5Prostatitis
09/2009 - 12/2006
4Reperfusion Injury
10/2023 - 01/2018
4Type 2 Diabetes Mellitus (MODY)
01/2019 - 10/2010
4Obesity
01/2018 - 12/2009
4Hypogonadism (Hypergonadotropic Hypogonadism)
01/2014 - 07/2012
4Hypercalcemia (Milk Alkali Syndrome)
06/2010 - 05/2004
3Liver Cirrhosis (Hepatic Cirrhosis)
01/2024 - 09/2013
3Liver Diseases (Liver Disease)
01/2024 - 10/2010
3Fatty Liver
11/2022 - 11/2018
3Dyslipidemias (Dyslipidemia)
01/2020 - 08/2011
3Disease Progression
01/2018 - 05/2002
3Diabetic Nephropathies (Diabetic Nephropathy)
01/2018 - 11/2010
3Hypoxia (Hypoxemia)
01/2017 - 01/2012
3Hyperglycemia
08/2011 - 11/2010
3Neoplasms (Cancer)
11/2008 - 01/2006
2Alcoholic Fatty Liver
10/2023 - 06/2022
2Metabolic Diseases (Metabolic Disease)
06/2022 - 10/2010
2Ischemia
04/2022 - 01/2018
2Hypercholesterolemia
01/2018 - 01/2018
2Kidney Diseases (Kidney Disease)
01/2017 - 01/2016
2Glucose Intolerance
01/2014 - 01/2011
2Colitis
04/2011 - 06/2010
2Rheumatoid Arthritis
01/2011 - 11/2004
2Carcinogenesis
11/2008 - 03/2007
2Breast Neoplasms (Breast Cancer)
11/2008 - 03/2007
2Psoriasis (Pustulosis Palmaris et Plantaris)
07/2007 - 06/2002
2Prostatic Neoplasms (Prostate Cancer)
03/2007 - 06/2006
2Pelvic Pain
02/2007 - 12/2006
2Hyperplasia
07/2005 - 02/2005
1Dysbiosis
11/2022
1Cholestasis
11/2021

Drug/Important Bio-Agent (IBA)

20obeticholic acidIBA
01/2024 - 11/2010
14Bile Acids and Salts (Bile Acids)IBA
01/2024 - 10/2010
14Calcitriol Receptors (Calcitriol Receptor)IBA
06/2010 - 06/2002
116-ethyl-24-norcholane-3,7,23-triol-23 sulfateIBA
11/2022 - 10/2010
10LipidsIBA
01/2024 - 12/2009
9Insulin (Novolin)FDA Link
01/2018 - 01/2002
8LigandsIBA
06/2022 - 06/2002
76alpha-ethyl-23(S)-methylcholic acidIBA
06/2022 - 10/2011
7BXL628IBA
04/2009 - 02/2005
6AcidsIBA
11/2022 - 12/2009
6Glucose (Dextrose)FDA LinkGeneric
06/2022 - 01/2011
6Messenger RNA (mRNA)IBA
01/2019 - 10/2002
5EnzymesIBA
01/2024 - 11/2010
5Interleukin-6 (Interleukin 6)IBA
01/2017 - 04/2009
5Vitamin DFDA LinkGeneric
01/2011 - 08/2004
5Calcitriol (Calcijex)FDA LinkGeneric
07/2007 - 10/2002
4Fatty Acids (Saturated Fatty Acids)IBA
11/2022 - 12/2009
4G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
06/2022 - 10/2010
4Hormones (Hormone)IBA
11/2017 - 04/2002
4CytokinesIBA
01/2017 - 02/2007
4Testosterone (Sustanon)FDA Link
10/2012 - 01/2012
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2010 - 06/2006
41,25-dihydroxyvitamin DIBA
06/2010 - 04/2002
4Interleukin-12 (IL 12)IBA
09/2009 - 05/2002
3Alanine Transaminase (SGPT)IBA
01/2024 - 09/2013
3CollagenIBA
01/2024 - 01/2017
3Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
11/2023 - 10/2010
3CholesterolIBA
11/2023 - 01/2019
3Proteins (Proteins, Gene)FDA Link
10/2023 - 02/2005
3Matrix Metalloproteinases (MMPs)IBA
10/2023 - 01/2020
3Streptozocin (Streptozotocin)FDA Link
01/2018 - 11/2010
3AndrogensIBA
07/2012 - 02/2005
3Interleukin-8 (Interleukin 8)IBA
01/2012 - 02/2007
3AutoantigensIBA
09/2009 - 05/2002
3rho-Associated KinasesIBA
04/2009 - 02/2007
3Peptides (Polypeptides)IBA
08/2007 - 05/2003
3ChemokinesIBA
02/2007 - 12/2002
2Galectin 3 (LGALS3)IBA
01/2024 - 12/2019
2Biomarkers (Surrogate Marker)IBA
12/2023 - 02/2007
2Ethanol (Ethyl Alcohol)IBA
01/2023 - 11/2018
2Glucagon-Like Peptide 1 (GLP 1)IBA
01/2019 - 10/2010
2Cholic AcidIBA
10/2018 - 07/2014
2Ursodeoxycholic Acid (Urso)FDA LinkGeneric
01/2018 - 04/2015
2Bleomycin (Blenoxane)FDA LinkGeneric
11/2017 - 01/2017
2SteroidsIBA
11/2017 - 12/2006
2MonocrotalineIBA
11/2017 - 01/2017
2Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2014 - 10/2012
2Dextrans (Dextran)FDA Link
04/2011 - 06/2010
2sodium sulfate (sodium bisulfate)FDA LinkGeneric
04/2011 - 06/2010
2NF-kappa B (NF-kB)IBA
04/2009 - 08/2004
2Cholecalciferol (Vitamin D3)FDA Link
11/2008 - 01/2006
2AntigensIBA
08/2005 - 11/2004
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2024
1Cysteine (L-Cysteine)FDA Link
10/2023
1Metalloproteases (Metalloproteinases)IBA
10/2023
11- (4- (3- (hydroxyimino)- 3- (2- methylpyridin- 4- yl)- 1- o- tolylpropyl)phenyl)piperidine- 4- carboxylic acidIBA
06/2022
1ProgesteroneFDA LinkGeneric
11/2021

Therapy/Procedure

5Therapeutics
06/2022 - 02/2005